Trials / Completed
CompletedNCT01299857
Long-term Clinical and Biological Evaluation of Patients With Severe Forms of Pemphigus Treated by Rituximab
EVALUATION CLINIQUE ET BIOLOGIQUE A LONG TERME DES PATIENTS ATTEINTS DE FORMES SEVERES DE PEMPHIGUS TRAITES PAR LE RITUXIMAB
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 22 (actual)
- Sponsor
- University Hospital, Rouen · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to study the midterm clinical evaluation, biological parameters and immune reconstitution after Rituximab treatment for Pemphigus.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Rituximab | 375mg/m2 |
Timeline
- Start date
- 2011-06-01
- Primary completion
- 2011-06-01
- Completion
- 2012-06-01
- First posted
- 2011-02-18
- Last updated
- 2012-09-13
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT01299857. Inclusion in this directory is not an endorsement.